Back Refine search Reset
Please choose a search criteria from below
Filters Clear all
Specialties
Treatments

100+ results found in London, UK

Sort by:
Showing 41 - 50 of 100+ results
Oncology
24 years of experience
Medical Oncology

Dr Sarker is a Senior Lecturer and Honorary Consultant in Medical Oncology at Guy’s and St Thomas’ NHS Foundation Trust, and King’s College Hospital NHS Foundation Trust. He specialises in the treatment of hepato-pancreatic-biliary malignancies: Liver Cancer, Bile Duct Cancer, Pancreatic Cancer, Neuro-endocrine Cancer, Adrenal Glands Cancer and Gall Bladder Cancer.

His main research focus is in the development of novel therapies for cancer, and together with Dr James Spicer, runs the Early Phase Clinical Trials Unit based at Guy’s Hospital. He is also actively involved in the management of hepato-pancreatic-biliary malignancies at King's College Hospital Liver Unit, and has a specific interest in the development of new therapies and molecular imaging for these tumours. Dr Sarker graduated in medicine from the University of Liverpool in 1997, and subsequently trained in internal medicine and medical oncology. In 2003 he was appointed to a Cancer Research UK Clinical Research Fellowship in the Drug Development Unit of The Royal Marsden Hospital and Institute of Cancer Research, leading to the award of a PhD. He completed his medical oncology training at The Royal Marsden in 2010.

 


Diseases, Medical Tests and Treatments
  • Chemotherapy
  • Molecular Imaging
  • Gastro-intestinal cancers
  • Neuro-endocrine cancers
  • Liver cancer
  • Bilary cancer
Read more
Haematology
31 years of experience
Blood Cancer

Dr Gupta is the Clinical Director for Haematology and Cancer at Lewisham and Greenwich NHS hospital. He is the principal investigator of TACTIC CoVID trial . Dr Gupta now taking patients at London Bridge Hospital also. Dr Gupta is a clinician with experience in clinical and laboratory haematology spanning more than 21 years. He obtained training at Kings College Hospital, London; Royal North Shore Hospital, Australia; National University Hospital (NUH), Singapore; and All India Institute of Medical Sciences (AIIMS), India. He obtained CCST from London Deanery at Kings College Hospital. His clinical research was on anthracycline toxicity in children suffering from acute lymphoblastic leukaemia.

As an academic, he is deeply interested in teaching and research and he is an Honorary Senior Clinical Lecturer at Brighton and Sussex medical school. In 2011, Dr Gupta became a consultant haematologist. He is specialised in haematology and oncology, with a deep interest in clotting disorders and anaemias. He was the lead research and development (R and D) in haematology at East Sussex healthcare, as well as at Lewisham and Greenwich NHS trust. He diagnoses and treats a variety of primary blood disorders (Clotting disorders, Bleeding disorders and Anaemias). Part of his services includes inpatient and outpatient chemotherapies for Multiple Myeloma, Lymphomas, Chronic Lymphocytic Leukaemia and Chronic Myeloid Leukaemia.

Dr. Gupta is also into day case and inpatient blood transfusion and iron infusion. Dr Gupta provides consultations at all the major private hospitals in and around Bromley and Orpington. He is on the panel of all the major health insurance providers. He belongs to the British Society of Haematology, European Haematology Association, Medical Protection Society and the American Society of Haematology. He is associated with some charitable organizations in the UK and in India. The awards he has received include the prestigious Glory of India award based on his academic and social contributions. He is a deep sports enthusiast and fitness freak. Based on his accreditation as a Yoga teacher, he holds weekly classes in Bromley. He married Dr Meenal Gupta, a renowned histo-pathologist, and their marriage produced two lovely daughters. Dr Sunil Gupta works at Lewisham and Greenwich NHS Trust as a Consultant haematologist and haem-oncologist.


Diseases, Medical Tests and Treatments

  • Diagnostic aspiration and trephine biopsy of bone marrow
  • Chemotherapy
  • Therapeutic venesection
  • Haem-oncology
  • Clotting disorders
  • Anaemias


Read more
Oncology
33 years of experience
Breast Cancer, Colorectal Cancer, Liver Cancer + 1more

Dr Gregory Wilson is a Consultant Medical Oncologist, based in Manchester at The Christie NHS Foundation Trust. Dr Wilson also sees patients privately at a range of centres, both in the north west and in London. His interests include breast and colorectal cancer and he has a particular focus on metastatic diseases and patients with liver metastases. Dr Wilson is the Lead Clinician for liver-directed therapies and he provides The Harley Street Clinic with both an advisory and visiting clinical service. He works closely with consultant oncology, surgery and radiology colleagues to provide liver-directed therapies for patients of the Harley Street Clinic and The London Oncology Clinic.

He advises on a range of treatment options including Selective Internal Radiation Therapy, Chemotherapy Saturation of the liver and DC beads, a novel drug delivery embolisation system for tumours in the liver. Dr Wilson is a member of the breast and gastrointestinal disease groups of The Christie Hospital and takes an active role in recruiting patients onto national and international clinical research trials of newer treatment regimes.

It is important that HCA is transparent about our relationship with those doctors who provide us with clinical guidance on delivering the best possible care to patients and operating our hospitals safely and efficiently. We set out here some of the ways in which we work together and the amount we pay this doctor for such services.

 

 

 


Diseases, Medical Tests and Treatments
  • Chemotherapy
  • Biological Therapy
  • Radiotherapy
  • Breast Cancer
  • Colorectal Cancer
  • Liver Cancer
Read more
Oncology
Offers video consultation
29 years of experience
Prostate Cancer, Bladder Cancer, Clinical Oncology

Dr Vinod Mullassery is a London-based consultant clinical oncologist who specialises in the management Prostate and Bladder cancers at Guy's and St Thomas' NHS Foundation Trust and the Prostate Centre, Harley Street. He treats patients with radiotherapy, chemotherapy and hormones. Dr Mullassery is the brachytherapy lead at the hospital and also implemented the image-guided interstitial brachytherapy programme for cervical cancer.

Dr Mullassery gained his MD in 1999 and continued training in oncology at the University College Hospital, Great Ormond Street Hospital, and the Mount Vernon Cancer Centre, where he later undertook a post-CCT fellowship in modern radiotherapy techniques. In 2013, he was awarded the prestigious American Brachytherapy Society HDR Scholarship Award. He has been visiting Brachytherapy Fellow at University of Leuven, Belgium and at University of California, Los Angeles. Dr Mullassery is actively involved in teaching and has previously held the post of Royal College Tutor and Post Graduate Faculty Lead at Guys Hospital. He was also the Deputy Firm Head for the GKT Medical School. He is also involved in research and is a Principal Investigator on a number of clinical trials. His areas of interest includes use of modern radiotherapy techniques for prostate cancer and oligometastatic disease.

Read more
Oncology
24 years of experience
Clinical Oncology

Dr Simon Hughes is Consultant Clinical Oncologist at Guy’s and St Thomas’ NHS Foundation Trust, and an Honorary Senior Lecturer at King’s College London School of Medical Education (GKT Medical School). He specialises in the treatment of Urological cancers: Bladder Cancer, Prostate Cancer and Radiotherapy for other Urological Cancers. Simon Hughes trained at Guy’s and St Thomas’ Hospitals Medical School, where he also gained a BSc with First Class honours (Anatomy). His specialist training in Clinical Oncology included posts at The Middlesex Hospital, University College London Hospitals, and Guy’s & St. Thomas’ Hospitals. He also spent over 2 years working in the Imaging Sciences Laboratories at Kings College London, and the Centre for Medical Image Computing at University College London developing novel radiotherapy techniques for the treatment of mobile tumours.


Simon continues to have an active role in Research and Development. He led the Clinical Oncology and Radiotherapy Research and Development Team at Guy’s and St. Thomas’ Hospitals for 5 years, and was also Radiotherapy Clinical Trials Lead for the South East London Cancer Network during this period. His research interests include tumour motion, radiotherapy dose escalation, integration of functional imaging into radiotherapy planning, and the combination of novel agents with radiotherapy. He is the UK lead for the ENZARAD Study, and is a member of several Trial Management Groups / Data Monitoring Committees. Simon’s other main interest is medical education. He is the Education and Training Lead for King’s Health Partners Comprehensive Cancer Centre; an Associate Clinical Dean at King’s College London School of Medical Education; and is the Clinical Education and Training Lead for King’s College London School of Cancer and Pharmacological Sciences. Nationally, Simon is the Treasurer for the British Uro-oncology Group; and was the co-opted oncologist for the British Association of Urological Surgeons: Oncology Section Committee from 2013-2017. He is also a past President of the Oncology Section of the Royal Society of Medicine (2011-2012), and served on council for over 10 years.


Diseases, Medical Tests and Treatments
  • Bladder Cancer
  • Prostate Cancer
  • Radiotherapy for other Urological Cancers
  • SABR / Cyberknife (for Urological Cancers)
  • Radionuclide Therapy (for Urological Cancers)
  • Bladder Cancer
  • Prostate Cancer
  • Radiotherapy for other Urological Cancers
  • SABR / Cyberknife (for Urological Cancers)
  • Radionuclide Therapy (for Urological Cancers)
Read more
Oncology
26 years of experience

Dr Laura Kenny is a Consultant in Medical Oncology and she specialises in breast cancer. She trained in medicine at Queen's University Belfast and after following initial registrar training, she moved to London to study for a PhD in translational molecular imaging in the Cyclotron Building, Imperial College London. Her NHS clinical practice is based at Charing Cross and Hammersmith Hospitals (part of Imperial College  Healthcare NHS Trust) and she also sees patients privately. In addition, Dr Kenny is a Clinical Senior Lecturer at Imperial College.

Dr Kenny was awarded a Westminster Medical School Oncology Trustee's fellowship and her research has focused on the use of novel PET radiotracers for studying proliferation (fluorothymidine (FLT)), angiogenesis (fluciclatide (AH-111585), and choline metabolism in breast cancer patients. Her work has been published in Cancer Research, Clinical Cancer Research, the Journal of Nuclear Medicine, and the European Journal of Molecular Imaging and Nuclear Medicine.

She was awarded a prestigious NIHR/MRC clinician scientist fellowship  in 2010, with the aim of the project being to establish new methods for defining the imaging phenotype in patients, which will help predict drug resistance and drug sensitivity at early timepoints to established and novel cancer therapeutic agents.  Her research has been recognised by the American Association of Cancer Research (Young Investigator Award), American Society of Clinical Oncology (Merit Award), British Cancer Research Meeting (Translational Research Award), and she also won the McElwain prize.

Dr Kenny was also appointed as Director of  Early Phase Clinical Trials in Cancer, where her aim is to expedite clinical drug development with novel approaches to clinical trials. She was also awarded an MRC DPFS project grant to study a new Affibody probe which will target her2 expression in breast cancer, this will be a first in man study and involves collaboration with four leading oncology centres in the UK. 


Diseases, Medical Tests and Treatments
  • Chemotherapy
  • Breast Cancer
Read more
Oncology
Offers video consultation
34 years of experience
Medical Oncology, Bladder Cancer, Lung Cancer + 4more

Dr Jonathan Shamash is a Consultant Oncologist and is the Lead in Acute Oncology at St Bartholomew’s Hospital and has a further NHS base at Queen’s Hospital, Romford. Dr Shamash also sees patients privately, including at Leaders in Oncology Care. He graduated from the University of Edinburgh in 1987 and then undertook post graduate training in London, gaining an MD in in-vitro modelling of lymphoma.

Dr Shamash sub-specialises in genito-urinary cancers and thoracic malignancies. He has a special interest in managing complex oncology problems and delivering intensive treatments, including high dose Interleukin-2 and high does chemotherapy in testicular cancer. . Dr Shamash also chairs the supra-regional germ cell tumour multidisciplinary meeting and is a member of the NCRI testis clinical studies group. He leads various clinical studies in the management of testicular and prostate cancer and has published widely.

Read more
Oncology
39 years of experience
Lung Cancer, Kaposi's Sarcoma, Medical Oncology + 1more

Prof Siow Ming Lee is Professor of Medical Oncology and Consultant Medical Oncologist at University College London Hospital (UCLH). He is an internationally recognised authority on lung cancer treatment and research.

He has led several National Cancer Research Institute (NCRI) lung cancer trials over the past three decades in UK, which have changed clinical practice and improved treatment outcomes for lung cancer patients.

His research team established the use of gemcitabine/carboplatin chemotherapy to treat lung cancer and this treatment remains the standard chemotherapy combination to treat squamous lung cancer. His innovative trials with thalidomide as a cancer weapon and the smart drug erlotinib to treat poor performance lung cancer patients received worldwide publicity including being featured on BBC Ten O’Clock News at launch. His ET trial was the first prospective biomarker chemotherapy trial with ERCC1 to select lung cancer patients for doublet chemotherapy and demonstrated that platinum combination is superior to non-platinum chemotherapy. His latest trials examine the role of atezolizumab immunotherapy to treat poor performance non-small cell lung cancer patients (IPSOS) and hydroxychloroquine to treat small cell lung cancer (Study 15). His team was also part of the international FLAURA and KEYNOTE-189 Investigators that established osimertinib and chemotherapy-pembrolizumab combination as standard first-line therapy to treat EGFR mutant and wild-type lung cancer respectively. His trials have been recognised at major international conferences with many invited Presidential, Plenary and Oral Presentations at World Lung Cancer Conference, ASCO and ESMO and resulted in several 1st or senior author publications in high impact journals. His practice-changing trials and 4* high impact research publications were used for the REF 2014 exercise which ranked UCL top for research in UK.

Professor Lee is the Clinical Lead for the UCLH Thoracic Medical Oncology Unit and chairs the London Lung Cancer Group, which has an international research reputation. He previously was chairperson for the NCRI Lung Cancer Advanced Disease Subgroup, NCRI Brain New-agents Clinical Subgroup and committee member of CTACC, NCRI Lung, NCRI Brain and NCRI Lymphoma Groups.


Diseases, Medical Tests and Treatments


  • Targeted therapies and immunotherapy for lung cancer 
  • Non-small cell lung cancer
  • Small lung cell cancer 
  • Malignant mesothelioma
  • Thymic carcinoma 
  • HIV-related cancers
Read more
Oncology
30 years of experience
Clinical Oncology

Dr Teresa Guerrero Urbano is a Consultant Clinical Oncologist and clinical lead for Radiotherapy at Guy’s and St Thomas’ NHS Foundation Trust and King’s College, London. She is honorary Senior Lecturer at the University of Surrey. Her areas of expertise include: Head & Neck Cancer, Non melanomatous skin cancer and Prostate cancer. Dr Guerrero Urbano has previously held senior Consultant Clinical Oncologist and Honorary Senior Lecturer positions at Royal Surrey County NHS Trust, Basingstoke and North Hampshire NHS Foundation Trust, University of Surrey. She was a Senior Research Fellow at University College London and a Clinical Cancer Research Fellow at the Institute of Cancer Research and Royal Marsden Hospital.

Dr Guerrero Urbano completed her oncology training at the Royal Marsden, Royal Surrey County and Guy’s and St Thomas’ Hospitals. She completed her PhD at the University of London in 2008. Dr Guerrero Urbano is joint Module Leader for the Respiratory, Head and Neck module, MSc in Oncology, Institute of Cancer Research. She offers weekly Oncology Seminars at St Luke’s Cancer Centre aimed at doctors, nurses, radiographers and physicists and monthly lectures at the post-graduate Medical School at the University of Surrey. She is a PhD and MD examiner. Her formal research evaluated technical and biological aspects of intensity-modulated radiotherapy at the Institute of Cancer Research/Royal Marsden Hospital. Dr Guerrero Urbano is particularly interested in the use of novel radiation techniques to minimize long-term side effects and the use of chemotherapy and targeted therapy to improve outcomes. Dr Guerrero Urbano has published her research widely and spoken at conferences worldwide.


Diseases, Medical Tests and Treatments
  • Head and neck cancer
  • Technical and biological aspects of image-guided radiotherapy (IGRT)
  • Intensity-modulated radiotherapy (IMRT)
  • Cancer imaging applied to radiotherapy treatments
  • Head and neck cancer
  • Technical and biological aspects of image-guided radiotherapy (IGRT)
  • Intensity-modulated radiotherapy (IMRT)
  • Cancer imaging applied to radiotherapy treatments
Read more
Oncology
15 years of experience
Breast Cancer, Medical Oncology

Dr Mark Nathan is a Consultant Medical Oncologist at Guy’s and St Thomas’ NHS Foundation Trust having joined in 2017.

He specialises in treating breast cancer, working at Guys Hospital as well as Kings Hospital and Queen Mary’s Hospital in Sidcup. He is involved in the running of clinical trials at Guys Hospital.

Dr Nathan originates from London and graduated from the Bart’s and the London Medical School in 2006. He undertook his basic training in and around North East London before returning to complete his higher Oncology training at St Bartholomew’s Hospital.

He spent three years obtaining his PhD as an AVON clinical research fellow at the Breakthrough Breast Cancer Research Centre where he also participated in clinics at the Royal Marsden Hospital.


Diseases, Medical Tests and Treatments
  • The management of early and metastatic breast cancer
  • The management of early and metastatic breast cancer
Read more